Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

18 study records (showing up to 30 per record type)

• Registered trial NCT06085417 Completed (results not assessed here)
  Comparison of the Effects of Dexamethasone and magnesıum Sulphate Used as Adjuvant in Infraclavicular Nerve Block.
  Condition or outcome area: Bupivacaine|Dexamethasone|Magnesıum Sulphate|Adjuvant
  2023-01-02 · Subject: Magnesium Sulfate; Magnesium sulfate · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05558397 Phase 4 Not completed: Unknown
  Epidural Association of Morphine and Ropivacaine for Cancer Pain Treatment
  Condition or outcome area: Cancer Pain|Opioid Use|Cost Analysis|Palliative Care|Epidural Route|Morphine-ropivacaine Association|Quality of Life|Rational Use of Medication
  2018-04-01 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT04794842 Early_Phase 1 Not completed: Active Not Recruiting
  Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection
  Condition or outcome area: Intratympanic Steroid Injection|Idiopathic Sudden Sensorineural Hearing Loss|Meniere Disease
  2021-08-01 · Subject: Phenylic Acid; Phenol; phenylic alcohol; hydroxybenzene; NCI-C50124; 582-EP2308872A1; UN 2312; 582-EP2284148A1; 582-EP2308875A1; 582-EP2275404A1 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02498171 Completed (results not assessed here)
  Labour Analgesia; Comparing a Combinations of Either Fentanyl or Bupivacaine With Intrathecal Morphine
  Condition or outcome area: Labor Pain
  2014-01 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02456142 Phase 4 Completed (results not assessed here)
  CAUDAL BUPIVACAINE VERSUS INTRAVENOUS MORPHINE ON TIME TO FIRST ANALGESIC REQUIREMENT
  Condition or outcome area: Post Operative Pain
  2015-07 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02410317 Phase 3 Completed (results not assessed here)
  Ropivacaine Through Continuous Infusion Versus Epidural Morphine for Postoperative Analgesia After Emergency Cesarean Section
  Condition or outcome area: Postoperative Pain
  2015-02 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03749408 Phase 2 / Phase 3 Completed (results not assessed here)
  Effect of Addition of Mannitol to Bupivacaine on IANB Success and Post-endodontic Pain
  Condition or outcome area: Irreversible Pulpitis
  2012-12 · Subject: MTL; Mannitol; d-mannitol; Osmitrol; Mannitol (VAN); 123897-58-5; M9546_SIAL; NCI-C50362; Mannidex; SDM No. 35 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05281081 Phase 4 Completed (results not assessed here)
  Intraperitoneal Instillation of Levobupivacaine With Morphine Versus Levobupivacaine With Magnesium Sulfate for Postoperative Analgesia
  Condition or outcome area: Post Operative Pain
  2021-01-01 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT04445636 Completed (results not assessed here)
  Efficacy of Dexmedetomidine Versus Morphine as an Adjunct to Bupivacaine in Caudal Anesthesia.
  Condition or outcome area: Anesthesia, Local
  2020-06-28 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03875274 Phase 4 Completed (results not assessed here)
  Morphine Added to Ropivacaine for FICB for Postoperative Analgesia
  Condition or outcome area: Postoperative Pain
  2017-04-01 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03502642 Phase 4 Completed (results not assessed here)
  Ropivacaine Continuous Wound Infusion Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery
  Condition or outcome area: Obstetric Pain
  2017-05-29 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT03051022 Completed (results not assessed here)
  Comparison Between Dexamethasone and Morphine as an Adjuvant to Bupivacaine for Post-operative Analgesia
  Condition or outcome area: Lower Extremities Fracture
  2016-05-01 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02566096 Phase 4 Completed (results not assessed here)
  Efficacy of Transverses Abdominis -Plane Block With Bupivacaine Versus Bupivacaine With Morphine Postoperatively
  Condition or outcome area: Abdominal Cancer
  2015-09 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT02284282 Completed (results not assessed here)
  Spinal Bupivacaine/Morphine in Laparoscopic Gastro-intestinal Surgery
  Condition or outcome area: Spinal Bupivacaine/Morphine in Laparoscopic Surgery
  2014-08 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00795223 Phase 4 Completed (results not assessed here)
  Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA
  Condition or outcome area: Post Operative Pain|Total Knee Replacement
  2008-10 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00636415 Completed (results not assessed here)
  Intra-Articular Morphine Versus Bupivacaine on Knee Motion in Patients With Osteoarthritis
  Condition or outcome area: Analgesia
  2004-06 · Subject: Morphine; (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE) · open the ingredient record · ClinicalTrials.gov
• Systematic review registration CRD42016044075 Registered protocol, no results here: Review Completed published
  Effectiveness and safety of fentanyl and morphine added to intrathecal bupivacaine for caesarean section
  Condition or outcome area: Patients coming for caesarean section generally undergo a spinal anesthetic rather than a general anesthetic. The most commonly used preparations for the spinal anesthetic use local anesthetic in combination with opioid. Commonly added opioids are morphine and fentanyl. It is not clear if the addition of opioid is superior in terms of clinical outcomes. These important outcomes include the onset of the block, the height or dermatomal spread of the block, the duration of the block, and the overal
  2016-08-02 · Subject: Morphine; Morphia; Morphium; Morphin; Morphinum; (-)-Morphine; Morphina; Ospalivina; Duromorph; 57-27-2 · open the ingredient record
• Publication PMID 32798562 Research model: Cell Experiment
  Capillarisin protects SH-SY5Y cells against bupivacaine-induced apoptosis via ROS-mediated PI3K/PKB pathway
  Condition or outcome area: neurological complications
  Life Sci · 2020 · Subject: Capillarisin; 56365-38-9; Capillarisine; 5,7-dihydroxy-2-(4-hydroxyphenoxy)-6-methoxychromen-4-one; DTXSID30204918; 2-(p-Hydroxyphenoxy)-6-methoxy-5,7-dihydroxychromone; 5,7-dihydroxy-2-(4-hydroxyphenoxy)-6-methoxy-chromen-4-one; 5,7-dihydroxy-2-(4-hydroxyphenoxy)-6-methoxy-4H-chromen-4-one; C08999; AC1NQYDG · open the ingredient record · DOI 10.1016/j.lfs.2020.118279